ProCE Banner Activity

CE / CME

PrEP Today: An HIV Prevention Revolution

Podcast Episodes

Hear from global experts Linda-Gail Bekker, MBChB, DCH, DTM&H, FCP(SA), PhD; Kenyon R. Farrow; Andrew Grulich, MBBS, PhD; Brittany Williams, PhD; Jean-Michel Molina, MD, PhD; and Beatriz Grinsztejn, MD, PhD, on how current PrEP regimens represent a revolutionary step forward in enabling many individuals to avoid HIV acquisition.

Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Pharmacists: 0.50 contact hour (0.05 CEUs)

Released: October 11, 2023

Expiration: October 10, 2024

No longer available for credit.

Share

Faculty

Jessica L. Adams

Jessica L. Adams, PharmD, AAHIVE

Scientific Director, Infectious Diseases
Clinical Care Options
New York, United States

Linda-Gail Bekker

Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD

Director and Professor, The Desmond Tutu HIV Centre, UCT
CEO, The Desmond Tutu Health Foundation
Cape Town, South Africa

Kenyon Farrow

Kenyon Farrow

Vice President of Policy
Point Source Youth
Contributing Editor
TheBody.com
Cleveland, Ohio

Beatriz Grinsztejn

Beatriz Grinsztejn, MD, PhD

Director of the STI/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases
FIOCRUZ
Rio de Janeiro, Brazil

Andrew Grulich

Andrew Grulich, MBBS, PhD

Head
HIV Epidemiology and Prevention Program
The Kirby Institute, UNSW Sydney
NSW Australia

Jean-Michel Molina

Jean-Michel Molina, MD, PhD

Professor of Infectious Diseases
University of Paris Cité
Head of the Department of Infectious Diseases
Hospital Saint-Louis and lariboisière
Paris, France

Brittany Williams

Brittany Williams, PhD

Assistant Professor of Higher Education and Student Affairs Administration
Department of Education 
University of Vermont 
Burlington, Vermont

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This program is intended for physicians, pharmacists, registered nurses, physician associates/physician assistants, and other healthcare professionals who care for persons at risk of HIV acquisition.

Program Learning Goal

The goal of this program is to improve learners’ knowledge and competence regarding the evolving field of HIV PrEP regimens and guideline-based recommendations.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Select the optimal current PrEP regimen for each patient that will maximize adherence, tolerability, and HIV prevention outcomes based on patient and regimen characteristics

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Program Director

Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD

Director and Professor, The Desmond Tutu HIV Centre, UCT
CEO, The Desmond Tutu Health Foundation
Cape Town, South Africa

Linda Gail-Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD: consultant/advisor/speaker: Gilead, Janssen, Johnson & Johnson, Merck, ViiV. 

Primary Author

Jessica L. Adams, PharmD, AAHIVE

Scientific Director, Infectious Diseases
Clinical Care Options
New York, United States

Jessica L. Adams, PharmD, AAHIVE, has no relevant financial relationships to disclose.

Kenyon Farrow,

Vice President of Policy
Point Source Youth
Contributing Editor
TheBody.com
Cleveland, Ohio

Kenyon R. Farrow has no relevant financial relationships to disclose.

Beatriz Grinsztejn, MD, PhD

Director of the STI/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases
FIOCRUZ
Rio de Janeiro, Brazil

Beatriz Grinsztejn, MD, PhD, has no relevant financial relationships to disclose.

Andrew Grulich, MBBS, PhD

Head
HIV Epidemiology and Prevention Program
The Kirby Institute, UNSW Sydney
NSW Australia

Andrew Grulich, MBBS, PhD: consultant/advisor/speaker: Sequirus, ViiV; researcher: ViiV. 

Jean-Michel Molina, MD, PhD

Professor of Infectious Diseases
University of Paris Cité
Head of the Department of Infectious Diseases
Hospital Saint-Louis and lariboisière
Paris, France

Jean-Michel Molina, MD, PhD: consultant/advisor/speaker: Gilead, Merck, ViiV.

Brittany Williams, PhD

Assistant Professor of Higher Education and Student Affairs Administration
Department of Education 
University of Vermont 
Burlington, Vermont

Brittany Williams, PhD, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from October 11, 2023, through October 10, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page
  2. Read the target audience, learning objectives, and faculty disclosures
  3. View and study the content in its entirety
  4. Submit answers to the post-test questions and evaluation questions online

You must receive a test score of 65 or better and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint Accreditation In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

 

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.5 contact hours (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number -  JA4008176-0000-23-255-H02-P 
Type of Activity: Knowledge 

Upon successfully completing the post-test with a score of 65 and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.